Research / CBT / Fundamental state Inspectable configuration
State dimensions Filing 0000950170-25-065336 General Corporate
Debt relative to revenue 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
137.71% · OPTIONAL · VALID
Capex intensity 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
7.69% · OPTIONAL · VALID
Operating cash generation 50th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
7.80% · OPTIONAL · VALID
Revenue growth 25th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-8.15% · CORE · VALID
Inventory pressure 65th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
57.80% · OPTIONAL · VALID
Gross margin 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
25.75% · CORE · VALID
Operating margin 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
17.31% · CORE · VALID
R&D intensity 70th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.60% · OPTIONAL · VALID
SBC intensity 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.64% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 36 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 125.44%
Current 137.71%
Delta 12.27% Capex Intensity Decreased
Previous 8.06%
Current 7.69%
Delta -0.37% Cash Generation Decreased
Previous 12.98%
Current 7.80%
Delta -5.19% Growth Decreased
Previous -0.31%
Current -8.15%
Delta -7.83% Inventory Pressure Increased
Previous 56.13%
Current 57.80%
Delta 1.67% Margin Increased
Previous 24.61%
Current 25.75%
Delta 1.14% Profitability Increased
Previous 16.23%
Current 17.31%
Delta 1.08% R And D Intensity Increased
Previous 1.47%
Current 1.60%
Delta 0.14% Sbc Intensity Decreased
Previous 0.84%
Current 0.64%
Delta -0.20% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.